Call: +8801842077322 || Email: abdullahpharma.bd@gmail.com
Facebook Twitter WhatsApp WhatsApp Telegram
  • CONTACT US
  • FAQs
Facebook Twitter WhatsApp WhatsApp Telegram
Abdullah Pharma Abdullah Pharma
Select category
  • Select category
  • Anti-Diabetic
    • Bladder Cancer
    • Breast Cancer
    • Colon & Rectal Cancer
    • Colorectal Cancer
  • BEST SELLER
  • Diabetic
    • Endometrial Cancer
    • Hepatitis B Virus
    • Hepatitis C Virus
    • Ibrutinib
    • Kidney Cancer
    • Leukaemia
    • Liver Cancer
    • Lung Cancer
    • Lymphoma
    • Mantle Cell Lymphoma
    • Melanoma
    • Non-Hodgkin
  • ONCOLOGY PRODUCTS
    • Ovarian Cancer
    • Pancreatic Cancer
    • Peritoneal Cancer
    • Primary Biliary Cirrhosis
    • Prostate Cancer
    • Renal Cell Carcinoma
    • Rheumatoid Arthritis
    • Thrombocytopenia
    • Thyroid Cancer
    • Tumors Cancer
Login / Register
0 Wishlist
0 Compare
0 items / £0.00
Menu
Abdullah Pharma Abdullah Pharma
0 items / £0.00
Browse Categories
  • Anti-Diabetic
  • Bladder Cancer
  • Breast Cancer
  • Colon & Rectal Cancer
  • Colorectal Cancer
  • Diabetic
  • Endometrial Cancer
  • Hepatitis B Virus
  • Hepatitis C Virus
  • Kidney Cancer
  • Ibrutinib
  • Liver Cancer
  • BEST SELLER
    • Leukaemia
    • Lung Cancer
    • Lymphoma
    • Mantle Cell Lymphoma
    • Melanoma
    • Non-Hodgkin
  • ONCOLOGY PRODUCTS
    • Ovarian Cancer
    • Pancreatic Cancer
    • Peritoneal Cancer
    • Primary Biliary Cirrhosis
    • Prostate Cancer
  • Renal Cell Carcinoma
  • Rheumatoid Arthritis
  • Thrombocytopenia
  • Thyroid Cancer
  • Tumors Cancer
  • Home
  • ONCOLOGY PRODUCTS
  • About Us
  • UPLOAD PRESCRIPTION
CRIZONIX 250 MG
Click to enlarge
HomeDiabeticMelanoma CRIZONIX 250 MG
Previous product
CRIZOCENT 250 MG
CRIZOCENT 250 MG
Back to products
Next product
DACLAXEN 60 MG
DACLAXEN 60 MG

CRIZONIX 250 MG

Compare
Add to wishlist
Categories: BEST SELLER, Endometrial Cancer, Hepatitis B Virus, Hepatitis C Virus, Kidney Cancer, Leukaemia, Mantle Cell Lymphoma, Melanoma, ONCOLOGY PRODUCTS, Ovarian Cancer, Pancreatic Cancer, Peritoneal Cancer Tags: ALECNIB 150 MG, CRIZONIX, CRIZONIX 250 MG, Everest Pharmaceuticals Ltd, Kinase Inhibitor, Medicine in Bangladesh, Oncology Medicine Supplier, Oncology Medicine Supplier in Bangladesh, Oncology Medicines, Oncology Medicines in Bangladesh
Share
Facebook Twitter WhatsApp WhatsApp Telegram
  • Description
  • Reviews (0)
  • Shipping & Delivery
Description

Capsule Crizonix Capsule

250 mg

Indications

Crizotinib is a kinase inhibitor indicated for the treatment of patients with- 

  • Metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive
  • Metastatic NSCLC whose tumors are ROS1-positive

Therapeutic Class

Targeted Cancer Therapy

Description

Crizotinib is a kinase inhibitor indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive or ROS 1 positive. Crizotinib is the first FDA-approved biomarker-driven therapy for both ALK positive and ROS1-positive metastatic NSCLC. It is the only FDA approved drug for ROS 1 positive NSCLC.

Pharmacology

Crizotinib is an inhibitor of receptor tyrosine kinases including ALK, Hepatocyte Growth Factor Receptor (HGFR, c-Met), ROS1 (c-ros), and Recepteur d’Origine Nantais (RON). Translocations can affect the ALK gene resulting in the expression of oncogenic fusion proteins. The formation of ALK fusion proteins results in activation and dysregulation of the gene’s expression and signaling which can contribute to increased cell proliferation and survival in tumors expressing these proteins. Crizotinib demonstrated concentration-dependent inhibition of ALK, ROS1, and c-Met phosphorylation in cell-based assays using tumor cell lines and demonstrated antitumor activity in mice bearing tumor xenografts that expressed echinoderm microtubule-associated protein-like 4 (EML4)- or nucleophosmin (NPM)-ALK fusion proteins or c-Met.

Dosage & Administration

Recommended Dose: 250 mg orally, twice daily 

Geriatric Use: No differences in safety or efficacy were observed between older and younger patients. Clinical studies of Crizotinib in patients with ROS1-positive metastatic NSCLC did not include sufficient numbers of patients age 65 years and older to determine whether they respond differently from younger patients

Pediatric Dose: The safety and effectiveness of Crizotinib in pediatric patients have not been established.

Renal impairment: 250 mg orally, once daily in patients with severe renal impairment (creatinine clearance <30 mL/min) not requiring dialysis. No starting dose adjustment is needed for patients with mild (ClCr 60-89 mL/min) or moderate (ClCr 30-59 mL/min) renal impairment based on a population pharmacokinetic analysis.

Hepatic Impairment: Caution should be used in patients with hepatic impairment

Interaction

CYP3A Inhibitors: Concurrent use of Crizotinib should be avoided with strong CYP3A inhibitors including but not limited to atazanavir, clarithromycin, indinavir, itraconazole, ketoconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, troleandomycin, and voriconazole 

CYP3A Inducers: Concurrent use of Crizotinib should be avoided with strong CYP3A inducers including but not limited to carbamazepine, phenobarbital, phenytoin, rifabutin, rifampin, and St. John’s Wort

CYP3A Substrates: Concurrent use of Crizotinib should be avoided with CYP3A substrates with narrow therapeutic indices including but not limited to alfentanil, cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus

Side Effects

The most common adverse reactions (≥25%) are vision disorders, nausea, diarrhea, vomiting, edema, constipation, elevated transaminases, fatigue, decreased appetite, upper respiratory infection, dizziness, and neuropathy.

Pregnancy & Lactation

Based on its mechanism of action, Crizotinib can cause fetal harm when administered to a pregnant woman. There are no available data on the use of Crizotinib during pregnancy. Females of reproductive potential should be advised of the potential risk to a fetus and use of effective contraception.
There is no information regarding the presence of Crizotinib in human milk, the effects on the breastfed infant, or the effects on milk production. Because of the potential for adverse reactions in breastfed infants patients should not breastfeed during treatment with Crizotinib and for 45 days after the final dose.

Precautions & Warnings

Hepatotoxicity: Patients should undergo periodic liver testing. Crizotinib should be temporarily suspended, dose reduced or permanently suspended 

Interstitial lung disease (ILD)/ Pneumonitis: Drug should be permanently discontinued in patients with ILD/ Pneumonitis

QT interval prolongation: Electrocardiograms and electrolytes in patients who have a history of or predisposition for QTc prolongation, or who are taking medications that prolong QT should be monitored. Crizotinib should be temporarily suspended, dose reduced or permanently suspended

Bradycardia: Crizotinib can cause bradycardia. Heart rate and blood pressure should be regularly monitored. Crizotinib should be temporarily suspended, dose reduced or permanently suspended

Severe visual loss: Ophthalmological evaluation should be performed. Crizotinib should be discontinued in severe visual loss

Embryo-fetal toxicity: Crizotinib can cause fetal harm. Females of reproductive potential should be advised of the potential risk to a fetus and use of effective contraception

/*54745756836*/

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “CRIZONIX 250 MG” Cancel reply

Your email address will not be published. Required fields are marked *

Shipping & Delivery
MAECENAS IACULIS Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing/*54745756836*/

Related products

AFANIX
Compare
Close

AFANIX 40 MG

Afatinib is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose
Add to wishlist
Read more
Quick view
AXINIX
Compare
Close

AXINIX 1 MG

Axinix (Axitinib) is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma after failure of one prior
Add to wishlist
Read more
Quick view
CABOZANIX
Compare
Close

CABOZANIX 60 MG

CABOZANIX 60 MG/*54745756836*/
Add to wishlist
Read more
Quick view
COVIRIN 200MG
Compare
Close

COVIRIN 200MG

Covirin Capsule 200 mg Indications Ribavirin is indicated for the treatment of chronic hepatitis C (CHC) virus infection in combination with
Add to wishlist
Read more
Quick view
IBRUNIB 140 MG
Compare
Close

IBRUNIB 140 MG

IBRUNIB Strength 140 mg Packing 1 X 30 Capsules (Plastic Container) Storage Store below 30°C. Keep capsules in the original
Add to wishlist
Read more
Quick view
DACLAXEN 60 MG
Compare
Close

DACLAXEN 60 MG

Indications Daclatasvir is indicated in combination with Sofosbuvir for the treatment of chronic hepatitis C virus (HCV) infection in adults.
Add to wishlist
Read more
Quick view
ALECNIB
Compare
Close

ALECNIB 150 MG

DESCRIPTION Alecnib, Alectinib Alecnib is an anti-cancer targeted chemotherapy drug used for the treatment of cancer. Alecnib is a tyrosine
Add to wishlist
Read more
Quick view
DISANIX 20
Compare
Close

DISANIX 20

DISANIX 20/*54745756836*/
Add to wishlist
Read more
Quick view
/*54745756836*/

Are you looking for an oncology medicine supplier in Bangladesh?We're offering medicine for all kinds of cancer. If you want to buy from a trusted supplier contact us.

48/A-B, Baitul Khair, Level-9, Purana Paltan,Dhaka-1000
Phone: +8801842077322
Whatsapp & WeChat: +8801842077322
Recent Posts
  • EXAMPLEARTICLE
    February 6, 2025 No Comments
  • Crazy Time Gioco Live, Stats At The Tracker In Pace Reale
    February 3, 2025 No Comments
Our Stores
  • Paltan
  • Banasree
  • Mirpur
  • Uttara
  • Gulshan
  • Banani
Useful links
  • Privacy Policy
  • Returns
  • Terms & Conditions
  • Contact Us
  • Latest News
  • About Us
Footer Menu
  • Instagram profile
  • New Collection
  • Oncology Product
  • Contact Us
  • Latest News
  • Liver Cancer
www.abdullahpharma.com 2021 CREATED BY -SHUKHI IT
payments
  • Menu
  • Categories
  • Anti-Diabetic
  • Bladder Cancer
  • Breast Cancer
  • Colon & Rectal Cancer
  • Colorectal Cancer
  • Diabetic
  • Endometrial Cancer
  • Hepatitis B Virus
  • Hepatitis C Virus
  • Kidney Cancer
  • Ibrutinib
  • Liver Cancer
  • BEST SELLER
    • Leukaemia
    • Lung Cancer
    • Lymphoma
    • Mantle Cell Lymphoma
    • Melanoma
    • Non-Hodgkin
  • ONCOLOGY PRODUCTS
    • Ovarian Cancer
    • Pancreatic Cancer
    • Peritoneal Cancer
    • Primary Biliary Cirrhosis
    • Prostate Cancer
  • Renal Cell Carcinoma
  • Rheumatoid Arthritis
  • Thrombocytopenia
  • Thyroid Cancer
  • Tumors Cancer
  • Home
  • ONCOLOGY PRODUCTS
  • About Us
  • UPLOAD PRESCRIPTION
  • Wishlist
  • Compare
  • Login / Register

Shopping cart

close

Sign in

close

Lost your password?
No account yet? Create an Account
Scroll To Top